Lantheus completed the acquisition of Life Molecular Imaging from Life Healthcare for $780m.

Lantheus, a radiopharmaceutical-focused company, completed the acquisition of Life Molecular Imaging, a radiopharmaceutical company, from Life Healthcare, a private healthcare provider, for $780m. "This acquisition aligns with our strategy to drive long-term growth and value creation by investing in high-potential, complementary assets and R&D capabilities to strengthen our radiopharmaceutical leadership," Brian Markison, Lantheus CEO.